An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy

Neurology

Volumn 69, Issue 3, 2007, Pages 250-254

  Striano, P ^a,b   Coppola, A ^a   Pezzella, M ^a   Ciampa, C ^a   Specchio, N ^c   Ragona, F ^d   Mancardi, M M ^b   Gennaro, E ^e   Beccaria, F ^f   Capovilla, G ^f   Rasmini, P ^g   Besana, D ^g   Coppola, G G ^h   Elia, M ⁱ   Granata, T ^d   Vecchi, M ^j   Vigevano, F ^c   Viri, M ^k   Gaggero, R ^b   Striano, S ^a   Zara, F ^b   more..

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e GALLIERA HOSPITAL   (Italy)

^f Ospedale C Poma   (United States)

^g Alessandria Hospital   (Italy)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ OASI RESEARCH INSTITUTE IRCCS   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

^k FATEBENEFRATELLI HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; ETIRACETAM; NITRAZEPAM; PHENOBARBITAL; PRIMIDONE; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; VOLTAGE DEPENDENT ANION CHANNEL 1; DRUG DERIVATIVE; PIRACETAM;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FISHER EXACT TEST; FOCAL EPILEPSY; FOLLOW UP; GENE MUTATION; HUMAN; MALE; MYOCLONUS EPILEPSY; ONSET AGE; PRIORITY JOURNAL; RANK SUM TEST; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; COMPARATIVE STUDY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPILEPSIES, MYOCLONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PIRACETAM;

EID: 34547564527     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000265222.24102.db     Document Type: Article

References (16)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
2. Ceulemans B, Boel M, Claes L, et al. Severe myoclonic epilepsy in infancy: toward an optimal treatment. J Child Neurol 2004;19:516-521.
3. Dravet C, Bureau M, Oguni H. Severe myoclonic epilepsy in infancy. Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 3rd ed. London: Libbey, 2002:81-104.
4. Nabbout R, Gennaro E, Dalla Bernardina B, et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 2003;60:1961-1967.
5. Madia F, Striano P, Gennaro E, et al. Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology 2006;67:1230-1235.
6. Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-9866.
7. Glauser TA, Ayala R, Elterman RD, et al. N159 Study Group. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66:1654-1660.
8. UCB/N166 study. Levetiracetam as add-on treatment of myoclonic jerks in adolescents + adults. ClinicalTrials. gov. Available at: http://clinicaltrials. gov/show/ NCT00150774.
9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
10. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 2000;9:590-594.
11. Coppola G, Capovilla G, Montagnini A, et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 2000;49:45-48.
12. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:1638-1642.
13. Oguni H, Hayashi K, Oguni M, et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 1994;35:1140-1145.
14. Kanazawa O. Refractory grand mal seizures with onset during infancy including severe myoclonic epilepsy in infancy. Brain Dev 2001;23:749-756.
15. Caraballo RH, Cersosimo RO, Sakr D, Cresta A, Escobal N, Fejerman N. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005;46:1539-1544.
16. Kasteleijn-Nolst Trenite DG, Marescaux C, Stodieck S, Edelbroek PM, Oosting J. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res 1996;25:225-330.